PMID: 9420045Jan 7, 1998Paper

Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae

Antimicrobial Agents and Chemotherapy
J ClancyW Yuan

Abstract

A strain of Streptococcus agalactiae displayed resistance to 14-, 15-, and 16-membered macrolides. In PCR assays, total genomic DNA from this strain contained neither erm nor mef genes. EcoRI-digested genomic DNA from this strain was cloned into lambda Zap II to construct a library of S. agalactiae genomic DNA. A clone, pAES63, expressing resistance to erythromycin, azithromycin, and spiramycin in Escherichia coli was recovered. Deletion derivatives of pAES63 which defined a functional region on this clone that encoded resistance to 14- and 15-membered, but not 16-membered, macrolides were produced. Studies that determined the levels of incorporation of radiolabelled erythromycin into E. coli were consistent with the presence of a macrolide efflux determinant. This putative efflux determinant was distinct from the recently described Mef pump in Streptococcus pyogenes and Streptococcus pneumoniae and from the multicomponent MsrA pump in Staphylococcus aureus and coagulase-negative staphylococci. Its gene has been designated mreA (for macrolide resistance efflux).

References

Jul 1, 1991·Antimicrobial Agents and Chemotherapy·R Leclercq, P Courvalin
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·I BroekaertN Raikhel
Jan 1, 1986·Annual Review of Biophysics and Biophysical Chemistry·D M EngelmanA Goldman
Jan 1, 1972·Molecular & General Genetics : MGG·A Adams, M Oishi
Jan 1, 1983·Molecular & General Genetics : MGG·H YamagataS Mizushima
Jun 5, 1983·Journal of Molecular Biology·D Hanahan
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·B Weisblum
Feb 1, 1994·Molecular Microbiology·W Pan, B G Spratt
Mar 1, 1994·Trends in Biochemical Sciences·K Lewis

❮ Previous
Next ❯

Citations

Dec 11, 1999·The Journal of Antimicrobial Chemotherapy·J M EntenzaP Moreillon
Nov 30, 2000·Current Infectious Disease Reports·G G Zhanel, J A Karlowsky
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Claire PoyartPatrick Trieu-Cuot
May 17, 2001·Antimicrobial Agents and Chemotherapy·F FitoussiE Bingen
Apr 9, 2001·The Journal of Pharmacy and Pharmacology·K Poole
May 7, 2005·Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health·G DenamielE Gentilini
Mar 18, 2000·Antimicrobial Agents and Chemotherapy·A PortilloC Torres
Jan 14, 2004·Drugs·Xian-Zhi Li, Hiroshi Nikaido
Jul 14, 2001·Antimicrobial Agents and Chemotherapy·D De MouyUNKNOWN AFICORPI-BIO Network. Association de Formation Continue en Pathologie Infectieuse des Biologistes
Oct 5, 2001·Clinical Microbiology Reviews·A C FluitF J Schmitz
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·B Vester, S Douthwaite
Jul 14, 2001·Antimicrobial Agents and Chemotherapy·G ClareboutR Leclercq
Feb 12, 2005·The Journal of Antimicrobial Chemotherapy·Rafael CantónGiuseppe Cornaglia
Oct 28, 2016·Critical Reviews in Microbiology·Cláudia GomesJoaquim Ruiz
Nov 19, 2002·Antimicrobial Agents and Chemotherapy·Eleonora GiovanettiPietro Emanuele Varaldo
Nov 30, 1999·Antimicrobial Agents and Chemotherapy·C ArpinC Quentin
Apr 2, 1999·Antimicrobial Agents and Chemotherapy·C ArpinC Quentin
Jan 26, 2002·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yoshinori Nakajima
Oct 6, 1999·Current Opinion in Microbiology·D T Chu
Sep 28, 2001·International Journal of Antimicrobial Agents·J C Pechère
Jun 29, 2007·Journal of Clinical Microbiology·Yongwei CaiGwendolyn L Gilbert
Feb 7, 2001·Journal of Clinical Microbiology·A JasirC Schalén
Mar 31, 2018·Microbiology Spectrum·Marisa HaenniJean-Yves Madec

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.